NCT05379621

Brief Summary

Socio-demographic factors in relation to the diagnosis of COVID cases are increasingly mentioned in the role of transmission, but unfortunately with a small number of conclusive publications on French data. Our objective is to analyse the distribution of cases according to these factors and their possible role during the first 6 weeks of 2021 when the Alpes Maritimes was the department with the highest incidence rate. The collaboration between ARS06 and the Public Health Department in the field of COVID-19 has made it possible to have a departmental bulletin for monitoring the evolution of the epidemic (incidence, screening, hospitalisation). Knowledge of the socio-demographic, meteorological and environmental factors associated with the transmission of SARS-CoV2 would make it possible to reflect on how to act on these factors and to implement a public health policy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28,377

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 14, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 16, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
Last Updated

May 18, 2022

Status Verified

May 1, 2022

Enrollment Period

1 month

First QC Date

May 16, 2022

Last Update Submit

May 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period.

    Weekly incidence rate in the Alpes Maritimes according to the age group, by district of Nice and town

    Between 03/01/2021 and 14/02/2021

Secondary Outcomes (2)

  • Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period according to participants' social and economic factors

    Between 03/01/2021 and 14/02/2021

  • Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period according to climatic factors

    Between 03/01/2021 and 14/02/2021

Interventions

All persons of legal age or not resident in the Alpes-Maritimes between 03/01/2021 and 14/02/2021 with a COVID-19 diagnosis.

Eligibility Criteria

Age0 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Population of legal age or not residing in the Alpes Maritimes department between 03/01/2021 and 14/02/2021, i.e. 1078729 inhabitants in the Alpes Maritimes, including 342979 in the city of Nice

You may qualify if:

  • Any person, adult or not, residing in the Alpes-Maritimes between 03/01/2021 and 14/02/2021 with a COVID-19 diagnosis.

You may not qualify if:

  • Non resident in the Alpes-Maritimes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de NICE

Nice, 06001, France

Location

Related Publications (1)

  • Marine Barjoan E, Chaarana A, Festraets J, Geloen C, Prouvost-Keller B, Legueult K, Pradier C. Impact of social and demographic factors on the spread of the SARS-CoV-2 epidemic in the town of Nice. BMC Public Health. 2023 Jun 6;23(1):1098. doi: 10.1186/s12889-023-15917-z.

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2022

First Posted

May 18, 2022

Study Start

January 3, 2021

Primary Completion

February 14, 2021

Study Completion

February 14, 2021

Last Updated

May 18, 2022

Record last verified: 2022-05

Locations